medigraphic.com
ISSN 2305-7939 (Electronic)

2019, Number 1

<< Back Next >>

RCU 2019; 8 (1)

Use of percutaneous nephrostomy in patients with obstructive renal failure

Rodríguez PR, Agüero GJL

Language: Spanish
References: 18
Page: 14-21
PDF size: 793.86 Kb.


ABSTRACT

Introduction: Percutaneous nephrostomy is the minimally invasive surgical technique that allows the transient or permanent placement of a catheter of adequate caliber inside the renal collecting system, for diagnostic or therapeutic purposes and is basically indicated for the treatment of obstructive conflicts of the upper urinary tract. Objective: To describe the results obtained with the use of percutaneous nephrostomy in the treatment of patients with obstructive renal failure in the Provincial General Teaching Hospital of ¨Antonio Luaces Iraola¨. Method: Were studied all patients with a diagnosis of obstructive renal failure in the three-year period who underwent percutaneous nephrostomy as part of the treatment. Results: A total of 48 patients were treated and 53 percutaneous nephrostomies were performed in the study period. Patientsolderthan 60 years, male, of the white race and from ¨Antonio Luaces Iraola¨ were the groups with the highest incidence. Neoplasics and lithiasic disease are the main etiological diagnoses of obstruction. Results: 140 transplants were performed, 103 of them (73.6 %) of cadaveric donation; 90 (94.3 %) of the male sex; 85 (60.7 %) whites and most adults under 60 years of age. There were no failure in the initial function 78 patients (55.7 %); ATN was presented in 34 cases (24.3 %) and associated with RA in 4 (2.9 %); the AR was presented in 4 cases (2.9 %). Conclusions: Percutaneous nephrostomy is a fast, safe procedure with a low rate of complications to treat obstructions of the upper urinary tract, as long as it is performed by personnel trained in endourological techniques.


REFERENCES

  1. Iturralde Codina AR, González León Y, Castillo Rodríguez M. Cirugía urológica de mínimo acceso. La Habana: Ciencias Médicas; 2010,

  2. Petriconi R, Zores T. Derivación del aparato urinario superior con catéter ureteral, doble J, nefrostomía o derivación interna, Principios, técnicas y complicaciones. EMC - Urología. 2014 [citado 12 Feb 2018];46(4):1-24. Disponible en: https://www,sciencedirect,com/science/article /pii/S1761331014694627

  3. Majid Rana A, Zaidi Z, EL-Khalid S. Single- Center Review of Fluoroscopy-Guided Percutaneous Nephrostomy Performed by Urologic Surgeons. Journal Endourology. 2007 [citado 12 Feb 2018];21(7). Disponible en: https://www,liebertpub,com/doi/abs/10,1089/ end,2006,0281

  4. Goodwin WE, Casey WC, Woolf W. Percutaneous trocar (needle) nephrostomy in hydronephrosis. JAMA. 1955 [citado 12 Feb 2018];157:891-4. Disponible en: https://books,google,com,cu/books?hl=es&lr= &id=CHR0E9A8k34C&oi=fnd&pg=PA448&dq=P ercutaneous+trocar+(needle)+nephrostomy+in +hydronephrosis,&ots=NZ4mC_JA5& sig=OZYdOc6xws6g1uuDOvCDU4RnZp0&re dir_esc=y#v=onepage&q=Percutaneous %20trocar %20(needle) %20nephrostomy %20in %20hydronephrosis,&f=false

  5. Sanchez-Periut E, Muro-Toledo G, Losada- Guerra J, Reyes-Almeida L. La nefrostomía percutánea en el carcinoma cérvico-uterino avanzado con uropatía obstructiva. Rev Mexicana Urol. 2016 [citado 12 Feb 2018];76(4):207-12. Disponible en: https://www,sciencedirect,com/science/article /pii/S2007408516300155

  6. Bhatt S, Verma P, Kumar Grover R, Sharma P, Rajaram S. Success, Effectiveness and Safety of Combined Sonographic and Fluoroscopic Guided Percutaneous Nephrostomy in Malignant Ureteral Obstruction. Med Grav. 2017 [citado 12 Feb 2018];3(1):1-6. Disponible en: https://www,google,com/url?sa=t&rct=j&q=&e src=s&source=web&cd=1&cad=rja&uact=8&ve d=0ahUKEwjo1MT6qLrbAhVFnq0KHTFUCecQF ggqMAA&url =http %3A %2F %2Fmedcraveonline,com %2FIJRRT %2FIJRRT- 03- 00048,php&usg=AOvVaw1WVbcgZoFQ2OoJRC VWlUvr

  7. Castillo Guerra F, Monzón Rey J, López Montes RS, Hernández P, de la Paz Pérez Y, González Carmona EG. Nefrostomía percutánea en el tratamiento del paciente obstruido. Rev Cubana Urol. 2013 [citado 12 Feb 2018];2(2). Disponible en: https://www,google,com/url?sa=t&rct=j&q=&e src=s&source=web&cd=1&cad=rja&uact=8&ve d=0ahUKEwjzgd28qbrbAhVNUK0KHVXNBMYQF ggqMAA&url=http %3A %2F %2Fwww,revurologia,sld,cu %2Findex,php %2Frcu %2Farticle %2Fview %2F87 %2F0&usg=AOvVaw0Eqqho5pNtOVoLacLAy1h6

  8. Galarza A, Palermo M, Duran G, Houghton E, Cena S, Sylvestre Begnis F, Giménez ME. Nefrostomía percutánea por uropatía obstructiva. PrenMéd Argent. 2014 [citado 12 Feb 2018];100(2):120-6. Disponible en: https://www,researchgate,net/profile/Mariano _Palermo/publication/261634753_Nefrostomia _percutanea_por_uropatia_obstructiva/links/ 00463534de037916ab000000/Nefrostomiapercutanea- por-uropatia-obstructiva,pdf

  9. Hsu L, Li H, Pucheril D, Hansen M, Littleton R, Peabody J, et al. Use of percutaneous nephrostomy and ureteral stenting in management of ureteral obstruction, World J Nephrol. 2016 [citado 12 Feb 2018];5(2):172-81. Disponible en: https://www,ncbi,nlm,nih,gov/pmc/articles/PM C4777789/

  10. Merino-Sala S, Valderrama-Illana P, Abad- Menor F, Moreno-Nores J, Lahoz-García C, González-Torres S, et al. Derivación urinaria urgente por patología obstructiva intrínseca o extrínseca de la vía urinaria. Stentureteral versus Nefrostomía percutánea. Actual Med. 2014 [citado 12 Feb 2018];99(791):6-9. Disponible en:http://digibug,ugr,es/bitstream/10481/3623 1/1/791_6,pdf

  11. Allen DJ, Longhorn SE, Philp T, Smith RD, Choong S. Percutaneousurinary drainage and ureteric stenting in malignant disease. ClinOncol (R CollRadiol). 2010 [citado 12 Feb 2018];22(9):733-9. Disponible en: http://www,clinicaloncologyonline,net/article/S 0936-6555(10)00260-8/abstract

  12. Ahmad I, Saeed Pansota M, Tariq M, Shahzad Saleem M, Ali Tabassum S, Hussain A. Comparison Between Double J (DJ) Ureteral Stenting and Percutaneous Nephrostomy (PCN) in Obstructive Uropathy. Pak J MedSci. 2013 [citado 12 Feb 2018];29(3):725-9. Disponible en: https://www,ncbi,nlm,nih,gov/pmc/articles/PM C3809292/

  13. Cuba, Oficina Nacional de Estadística e Información. Anuario Estadístico. 15ta ed.; 2015.

  14. Misra S, Jonathan Richenberg ChC. Percutaneous nephrostomy for ureteric obstruction due to advanced pelvic malignancy: have we got the balance right? IntUrolNephrol. 2013 [citado 12 Feb 2018];45:627-32. Disponible en: https://link,springer,com/article/10,1007/s112 55-013-0458-3

  15. Rodríguez-Pontones JA, Bretón-Reyes D. Complicaciones en pacientes sometidos a nefrostomía percutánea guiada por ultrasonido y factores asociados. GacMedMex. [citado 12 Feb 2018];152:167-72. Disponible en: http://www,medigraphic,com/pdfs/gaceta/gm- 2016/gm162e,pdf

  16. Cardona AF, Garzón JR, Burgos E, Abenoza LM, Crtés JA, Ramos PL. Mortalidad y complicaciones asociadas a nefrostomías percutáneas en pacientes con cáncer avanzado de cuello uterino. RevColombCancerol. 2005 [citado 12 Ene 2018];9(3):73-81. Disponible en: https://www,researchgate,net/profile/Jorge_C ortes6/publication/6541391_Mortality_and_co mplications_associated_with_percutaneous _nephrostomy_in_patients_with_ureteral_obst ruction_related_to_advanced_cervical_cancer/l inks/56e9431708ae693eaf278eb0,pdf

  17. Díaz Sariego ME, Sariego Quintana IM, Díaz Macías B, Véñiz Santana J. Uropatia Obstructiva alta, Aspectos Clínicos epidemiológicos y terapéuticos. Multimed. RevMedGranma. 2015 [citado 12 Ene 2018];19(6). Disponible en: http://www,medigraphic,com/pdfs/multimed/ mul-2015/mul156m,pdf

  18. Ocampo ML, Musso CG. Nefropatia Obstructiva. Asociación colombiana de nefrol e IpertArterial. Buenos Aires; 2017 [citado 12 Ene 2018]. Disponible en: http://asocolnef,com/wpcontent/ uploads/2018/02/Cap %C3 %ADtulo- %E2 %80 %93-Nefropat %C3 %ADa-Obstructiva-pdf




2020     |     www.medigraphic.com